Publications

5677 Results

Radiotherapy Use and Incidence of Locoregional Recurrence in Patients with Favorable-Risk Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial

Authors
R Jagsi;W Barlow;W Woodward;E Connolly;R Mahtani;D Shumway;C Speers;S Stecklein;Y Zeidan;H Zhang;P Sharma;L Pusztai;G Hortobagyi;K Kalinsky
Journal / Conference
JAMA Oncology Aug 1;9(8):1083-1089
Year
2023
Research Committee(s)
Breast
PMID
PMID37410451
PMC
PMC10326730
Study Number(s)
S1007

Genetically Adjusted PSA Levels for Prostate Cancer Screening

Authors
L Kachuri;T Hoffmann;Y Jiang;S Berndt;J Shelley;K Schaffer;M Machiela;N Freedman;W Huang;S Li;R Easterlin;P Goodman;C Till;I Thompson;H Lilja;S Van Den Eeden;S Chanock;C Haiman;D Conti;R Klein;J Mosley;R Graff;J Witte
Journal / Conference
Nature Medicine Jun;29(6):1412-1423
Year
2023
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID37264206
PMC
PMC10287565
Study Number(s)
S0000, SWOG-9217

Crisis of the clinical trials staff attrition following the COVID-19 pandemic [Editorial]

Authors
G Sun;D Dizon;C Szczepanek;D Petrylak;D Sparks;C Tangen;P Lara;I Thompson;CD Blanke
Journal / Conference
JCO Oncology Practice Aug;19(8):533-535
Year
2023
PMID
PMID37285550
PMC
PMC10424897

ASO Visual Abstract: Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers - Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).

Authors
S Gholami;S Colby;D Horowitz;K Guthrie;A El-Khoueiry;CD Blanke;PA Philip;L Kachnic;S Ahmad;F Rocha
Journal / Conference
ANNALS OF SURGICAL ONCOLOGY
Year
2023
Research Committee(s)
Gastrointestinal
PMID
PMID36542251
Study Number(s)
S0809

Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses

Authors
N Dimou;A Kim;O Flanagan;N Murphy;V Diez-Obrero;A Shcherbina;E Aglago;E Bouras;P Campbell;G Casey;S Gallinger;S Gruber;M Jenkins;Y Lin;V Moreno;E Ruiz-Narvaez;M Stern;Y Tian;K Tsilidis;V Arndt;E Barry;J Baurley;S Berndt;S Bezieau;S Bien;T Bishop;H Brenner;A Budiarto;R Carreras-Torres;T Wawan Cenggoro;A Chan;J Chang-Claude;S Chanock;X Chen;D Conti;C Dampier;M Devall;D Drew;J Figueiredo;G Giles;A Gsur;T Harrison;A Hidaka;M Hoffmeister;J Huyghe;K Jordahl;E Kawaguchi;T Keku;S Larsson;L Le Marchand;J Lewinger;B Mahesworo;J Morrison;P Newcomb;C Newton;M Obon-Santacana;J Ose;R Pai;J Palmer;N Papadimitrou;B Pardamean;A Peoples;P Pharoah;E Platz;J Potter;G Rennert;P Scacheri;R Schoen;Y Su;C Tangen;S Thibodeau;D Thomas;C Ulrich;C Um;F van Duijnhoven;K Visvanathan;P Vodicka;L Vodickova;E White;A Wolk;M Woods;C Qu;A Kundaje;L Hsu;W Gauderman;M Gunter;U Peters
Journal / Conference
British Journal of Cancer Aug;129(3):511-520
Year
2023
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID37365285
PMC
PMC10403521
Study Number(s)
S0000

Genetic susceptibility to nonalcoholic fatty liver disease and risk for pancreatic cancer: Mendelian randomization

Authors
SD King;S Veligenti;M Brouwers;Z Ren;W Zheng;V Setiawan;L Wilkens;X Shu;A Arslan;L Beane Freeman;P Bracci;F Canzian;M Du;S Gallinger;G Giles;P Goodman;C Haiman;M Kogevinas;C Kooperberg;L Le Marchand;R Neale;K Visvanathan;E White;D Albanes;G Andreotti;A Babic;S Berndt;L Brais;P Brennan;J Buring;K Rabe;W Bamlet;S Chanock;C Fuchs;J Gaziano;E Giovannucci;T Hackert;M Hassan;V Katzke;R Kurtz;I Lee;N Malats;N Murphy;A Oberg;I Orlow;M Porta;F Real;N Rothman;H Sesso;D Silverman;IM Thompson;J Wactawski-Wende;X Wang;N Wentzensen;H Yu;A Zeleniuch-Jacquotte;K Yu;B Wolpin;E Duell;D Li;R Hung;S Perdomo;M McCullough;M Freedman;A Patel;U Peters;E Riboli;M Sund;A Tjonneland;J Zhong;S Van Den Eeden;P Kraft;H Risch;L Amundadottir;A Klein;R Stolzenberg-Solomon;S Antwi
Journal / Conference
Cancer Epidemiology, Biomarkers & Prevention Sep 1;32(9):1265-1269
Year
2023
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID37351909
PMC
PMC10529823
Study Number(s)
S0000

The effect of old age treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG Oncology Group/Gynecologic Oncology Group study

Authors
T Sia;W Tew;C Purdy;D Chi;A Menzin;J Lovecchio;M Bookman;D Cohn;D Teoh;M Friedlander;D Bender;D Mutch;D Gershenson;K Tewari;R Wenham;A Hendrickson;R Lee;H Gray;A Alvarez Secord;L Van Le;S Lichtman
Journal / Conference
Gynecologic Oncology Jun;173:130-137
Year
2023
Research Committee(s)
Gynecologic
PMID
PMID37148580
PMC
PMC10414765
Study Number(s)
G0182

Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial

Authors
CW Ryan;C Tangen;E Heath;M Stein;M Meng;A Alva;S Pal;I Puzanov;J Clark;T Choueiri;N Agarwal;R Uzzo;N Haas;T Synold;M Plets;U Vaishampayan;B Shuch;IM Thompson;PN Lara
Journal / Conference
Lancet Sep 23;402(10407):1043-1051
Year
2023
Research Committee(s)
Genitourinary
PMID
PMID37524096
PMC
PMC10622111
Study Number(s)
S0931

Granulomatous and Sarcoid-like Immune Related Adverse Events Following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and A Literature Review

Authors
I Eljilany;A Noor;M Paravathaneni;I Yassine;S Lee;M Othus;J Moon;J Kirkwood;V Sondak;A Ribas;K Grossmann;A Tarhini
Journal / Conference
Cancers (Basel) Apr 29;15(9):2561
Year
2023
Research Committee(s)
Melanoma
PMID
PMID37174027
PMC
PMC10177189
Study Number(s)
CTSU/E1609, S1404